Jiao Jing-Yi, Zhu Xiao-Jun, Zhou Chun, Wang Peng
Department of Hepatobiliary and Pancreatic Surgery, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Medical School, Nantong University, Nantong 226001, Jiangsu Province, China.
World J Gastrointest Surg. 2022 Sep 27;14(9):887-895. doi: 10.4240/wjgs.v14.i9.887.
Cholesterol gallstones are very common in hepatobiliary surgery and have been studied to a certain extent by doctors worldwide for decades. However, the mechanism of cholesterol gallstone formation is not fully understood, so there is currently no completely effective drug for the treatment and prevention of cholesterol gallstones. The formation and development of cholesterol gallstones are caused by a variety of genetic and environmental factors, among which genetic susceptibility, intestinal microflora disorders, impaired gallbladder motility, and immune disorders are important in the pathogenesis of cholesterol gallstones. This review focuses on recent advances in these mechanisms. We also discuss some new targets that may be effective in the treatment and prevention of cholesterol gallstones, which may be hot areas in the future.
胆固醇结石在肝胆外科中非常常见,几十年来全球医生对其进行了一定程度的研究。然而,胆固醇结石形成的机制尚未完全明确,因此目前尚无完全有效的药物用于治疗和预防胆固醇结石。胆固醇结石的形成和发展是由多种遗传和环境因素引起的,其中遗传易感性、肠道微生物群紊乱、胆囊运动功能受损和免疫紊乱在胆固醇结石的发病机制中起着重要作用。本文综述聚焦于这些机制的最新进展。我们还讨论了一些可能对治疗和预防胆固醇结石有效的新靶点,这些可能是未来的热点领域。